Solid Biosciences is trading 5.04% up at $7.20, with no confirmed company-specific catalyst for the move on October 5, 2026. - The company’s investor-relations release page lists no announcement dated October 5; its latest listed release is from September 2. - The S&P 500 is up 0.85% and the Nasdaq Composite is up 1.28%. The positive market backdrop may be contributing, but available evidence does not establish it as the direct cause of the stock’s gain.